Does Harvard Pilgrim Cover Weight Loss Medication? Exceptions and Appeals

Harvard Pilgrim does not cover weight loss medication for most members in 2026. Effective January 1, 2026, the insurer excluded all weight loss drugs — including GLP-1 medications prescribed for obesity or related conditions like cardiovascular disease — from its individual, small group, merged market, and large group commercial pharmacy benefit. GLP-1s prescribed to treat diabetes remain covered.1Harvard Pilgrim Health Care. Important Drug Coverage Updates for Harvard Pilgrim Health Care Members

What the Exclusion Covers

The exclusion is broad. It applies to GLP-1 drugs when prescribed for weight loss or what Harvard Pilgrim calls “alternative indications,” such as cardiovascular disease or other obesity-related comorbidities. Prior authorizations that had been approved for weight management were terminated on January 1, 2026, with no grandfathering of existing users.2Point32Health. Update on Coverage for Weight Loss Medication

If you are on a self-insured employer plan or certain large group products, the exclusion kicks in on your group’s 2026 anniversary date rather than January 1.2Point32Health. Update on Coverage for Weight Loss Medication Harvard Pilgrim recommends checking your specific 2026 plan materials, because some employer-sponsored plans may differ from the standard policy.1Harvard Pilgrim Health Care. Important Drug Coverage Updates for Harvard Pilgrim Health Care Members

The Diabetes Exception

GLP-1 medications prescribed to treat diabetes are still covered. The exclusion targets only weight loss and alternative indications.1Harvard Pilgrim Health Care. Important Drug Coverage Updates for Harvard Pilgrim Health Care Members

Diabetes coverage itself is tightening, though. Effective May 1, 2026, Point32Health removed an automated step therapy program that had let claims clear at the pharmacy counter if a member had a recent oral diabetes prescription. Ozempic, Mounjaro, Trulicity, Rybelsus, Bydureon BCise, and Byetta now require prior authorization. To qualify, you need a Type 2 diabetes diagnosis and documentation that you have tried or are currently taking an oral hypoglycemic agent.3Point32Health. Update on Diabetic GLP-1 and GIP/GLP-1 Drug Coverage

When a Large Employer Buys Up Coverage

Some large employer groups can purchase a “Premium” formulary that keeps weight loss medication coverage. Under that formulary, Zepbound is the preferred weight-loss GLP-1, and coverage still requires prior authorization and medical necessity review.4Point32Health. Update on Coverage for Weight Loss Medication

If you are new to a weight-loss GLP-1 under a plan that covers them, starting in 2026 you must complete a six-month behavior modification program before becoming eligible for the medication. Members already on the drug are not subject to this requirement.2Point32Health. Update on Coverage for Weight Loss Medication

Requesting a Formulary Exception

You can ask Harvard Pilgrim to make an exception. Your provider submits a statement explaining why the drug is medically necessary and why covered alternatives would not work as well. Harvard Pilgrim must decide within 72 hours or two business days, whichever is shorter. Urgent requests get a 24-hour turnaround. A denial can be appealed internally, and expedited external review may also be available.5Harvard Pilgrim Health Care. Request an Exception

One caveat for ConnectorCare enrollees: the ConnectorCare formulary documentation states that drugs excluded under the pharmacy benefit “will not be covered through this process.” The medical exception pathway may not reach outright exclusions in subsidized plans.6OptumRx. Value ConnectorCare 3-Tier 2026 Prescription Drug List

Paying Out of Pocket

If your plan excludes the drug and your doctor still considers it medically necessary, you pay the full cost. Harvard Pilgrim points members toward prescription discount cards and manufacturer copay assistance programs to bring that number down.1Harvard Pilgrim Health Care. Important Drug Coverage Updates for Harvard Pilgrim Health Care Members

Weight Management Benefits That Remain

Harvard Pilgrim still reimburses certain weight management program fees. Eligible members can get reimbursement for up to 12 weeks of membership fees per calendar year for WW (Weight Watchers) digital programs or workshops, or for hospital-based weight management programs approved by Harvard Pilgrim.7Harvard Pilgrim Health Care. Weight Management Reimbursement

The reimbursement does not cover individual nutritional counseling, weight loss medications, registration fees, prepackaged meals, or supplies like books and scales. You must be enrolled in Harvard Pilgrim at the time of reimbursement, and eligibility varies by employer and plan. Verify yours through your secure online account or by calling Member Services at 888-333-4742.7Harvard Pilgrim Health Care. Weight Management Reimbursement

Medicare Members and the GLP-1 Bridge

Harvard Pilgrim’s member announcement refers broadly to “most 2026 plans” without specifically addressing Stride, its Medicare Advantage product.1Harvard Pilgrim Health Care. Important Drug Coverage Updates for Harvard Pilgrim Health Care Members

Separately from any plan-level decision, Medicare beneficiaries now have federal access to weight loss GLP-1s. The Medicare GLP-1 Bridge launched July 1, 2026, and covers Wegovy and Zepbound at a flat $50 copay per supply. Humana manages the program centrally. It operates independently of any Part D plan and does not require plans to opt in. Beneficiaries in standalone Part D plans or Medicare Advantage plans with drug coverage are eligible if they meet BMI and health criteria and receive prior authorization through the Bridge Program.8Centers for Medicare & Medicaid Services. Medicare GLP-1 Bridge

Bridge copays do not count toward Part D deductibles or out-of-pocket limits. The program is designed as a short-term measure ahead of the BALANCE Model, whose timeline has been uncertain.9Medicare Rights Center. GLP-1 Weight Loss Drug Demonstration Begins July 2026

Can the Courts Force Coverage?

Not through the avenues tried so far. The U.S. Court of Appeals for the First Circuit, which covers Massachusetts, has twice rejected challenges to weight loss drug exclusions. In Whittemore v. Cigna Health & Life Insurance Co., decided February 19, 2026, the court held that an obesity diagnosis and a weight loss prescription are not enough on their own to establish a disability under the Americans with Disabilities Act.10Thomson Reuters. First Circuit Rejects ACA Section 1557 Challenge to Plan’s Weight Loss Drug Exclusion In Holland v. Elevance Health, Inc., decided March 27, 2026, the same court rejected a class action under Section 1557 of the Affordable Care Act, finding the exclusion facially neutral and that the ACA does not require coverage of “every form of medically necessary treatment for a disabled individual’s particular condition.”11U.S. Court of Appeals for the First Circuit. Holland v. Elevance Health, Inc., No. 25-1359 State legislatures could still mandate coverage, but as of now, suing your way to a GLP-1 prescription is not a realistic path.